Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 16/20 | 0.46 |
| ▸ | HTR2A | P28223 | 16/20 | 0.46 |
| ▸ | DRD3 | P35462 | 16/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | HTR1D | P28221 | 2/20 | 0.42 |
| ▸ | HTR1B | P28222 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8548534 | 0.95 | DRD2 (0.48) | DRD2HTR2ADRD3MAPT | |
| SCHEMBL8553701 | 0.84 | BCHE (0.43) | MAPTALOX15L3MBTL1HTR1DHTR1B | |
| SCHEMBL7478444 | 0.84 | HTR1D (0.63) | DRD2HTR1DHTR1B | |
| SCHEMBL8548196 | 0.83 | DRD2 (0.52) | DRD2HTR2ADRD3 | |
| SCHEMBL8708281 | 0.79 | DRD2 (0.45) | DRD2HTR2ADRD3 | |
| SCHEMBL7484304 | 0.79 | HTR1D (0.58) | DRD2HTR1DHTR1B | |
| SCHEMBL8387125 | 0.76 | RAB9A (0.42) | DRD2HTR2ADRD3MAPTALOX15 | |
| SCHEMBL8550257 | 0.76 | DRD2 (0.54) | DRD2HTR2ADRD3HTR1DHTR1B | |
| SCHEMBL30909276 | 0.76 | RAB9A (0.42) | DRD2HTR2ADRD3MAPTALOX15 | |
| SCHEMBL8546763 | 0.76 | HTR1D (0.45) | DRD2HTR2ADRD3HTR1DHTR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5792763-A | MIGRAINES; ANALGESICS; DISEASES LINKED TO DECREASED NEUROTRANMISSION OF SEROTONIN IN MAMMALS | ELI LILLY AND COMPANY (US) | 1998-08-11 | — | — | US | disclosed |
| WO-1998015545-A1 | NEW SEROTONIN 5-HT1F AGONISTS | ELI LILLY AND COMPANY (US) | 1998-04-16 | — | — | WO | disclosed |
| EP-0835869-A2 | New serotonin 5-HT1F agonists | ELI LILLY AND COMPANY (US) | 1998-04-15 | — | — | EP | disclosed |